173 related articles for article (PubMed ID: 36797095)
1. Thermal and Acoustic Stabilization Of Volatile Phase-Change Contrast Agents Via Layer-By-Layer Assembly.
Alcaraz PE; Davidson SJ; Shreeve E; Meuschke R; Romanowski M; Witte RS; Porter TR; Matsunaga TO
Ultrasound Med Biol; 2023 May; 49(5):1058-1069. PubMed ID: 36797095
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic preparation of various perfluorocarbon nanodroplets: Characterization and determination of acoustic droplet vaporization (ADV) threshold.
Melich R; Bussat P; Morici L; Vivien A; Gaud E; Bettinger T; Cherkaoui S
Int J Pharm; 2020 Sep; 587():119651. PubMed ID: 32707242
[TBL] [Abstract][Full Text] [Related]
3. Fluorous-phase iron oxide nanoparticles as enhancers of acoustic droplet vaporization of perfluorocarbons with supra-physiologic boiling point.
Vezeridis AM; de Gracia Lux C; Barnhill SA; Kim S; Wu Z; Jin S; Lux J; Gianneschi NC; Mattrey RF
J Control Release; 2019 May; 302():54-62. PubMed ID: 30928487
[TBL] [Abstract][Full Text] [Related]
4. Repeated Acoustic Vaporization of Perfluorohexane Nanodroplets for Contrast-Enhanced Ultrasound Imaging.
Namen AV; Jandhyala S; Jordan T; Luke GP
IEEE Trans Ultrason Ferroelectr Freq Control; 2021 Dec; 68(12):3497-3506. PubMed ID: 34191726
[TBL] [Abstract][Full Text] [Related]
5. Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound.
Sheeran PS; Luois S; Dayton PA; Matsunaga TO
Langmuir; 2011 Sep; 27(17):10412-20. PubMed ID: 21744860
[TBL] [Abstract][Full Text] [Related]
6. Pulse sequences for uniform perfluorocarbon droplet vaporization and ultrasound imaging.
Puett C; Sheeran PS; Rojas JD; Dayton PA
Ultrasonics; 2014 Sep; 54(7):2024-33. PubMed ID: 24965563
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the Acoustic Vaporization Threshold of Lipid-Coated Perfluorobutane Nanodroplets Using Both High-Speed Optical Imaging and Acoustic Methods.
Wu Q; Mannaris C; May JP; Bau L; Polydorou A; Ferri S; Carugo D; Evans ND; Stride E
Ultrasound Med Biol; 2021 Jul; 47(7):1826-1843. PubMed ID: 33820668
[TBL] [Abstract][Full Text] [Related]
8. Vaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validation.
Doinikov AA; Sheeran PS; Bouakaz A; Dayton PA
Med Phys; 2014 Oct; 41(10):102901. PubMed ID: 25281982
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Behavioral Evaluation of Condensed Lipid-Coated Perfluorocarbon Nanodroplets.
Melich R; Emmel P; Vivien A; Sechaud F; Mandaroux C; Mhedhbi S; Bussat P; Tardy I; Cherkaoui S
Ultrasound Med Biol; 2024 Jul; 50(7):1010-1019. PubMed ID: 38637170
[TBL] [Abstract][Full Text] [Related]
10. Vaporization Detection Imaging: A Technique for Imaging Low-Boiling-Point Phase-Change Contrast Agents with a High Depth of Penetration and Contrast-to-Tissue Ratio.
Rojas JD; Dayton PA
Ultrasound Med Biol; 2019 Jan; 45(1):192-207. PubMed ID: 30482709
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Acoustic Activation of Phase Change Contrast Agents With the Activation Pressure Matching Method: A Review.
Rojas JD; Dayton PA
IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):264-272. PubMed ID: 27740481
[TBL] [Abstract][Full Text] [Related]
12. Effects of microchannel confinement on acoustic vaporisation of ultrasound phase change contrast agents.
Lin S; Zhang G; Leow CH; Tang MX
Phys Med Biol; 2017 Aug; 62(17):6884-6898. PubMed ID: 28718774
[TBL] [Abstract][Full Text] [Related]
13. Slow-Flow Ultrasound Localization Microscopy Using Recondensation of Perfluoropentane Nanodroplets.
Burgess MT; Aliabouzar M; Aguilar C; Fabiilli ML; Ketterling JA
Ultrasound Med Biol; 2022 May; 48(5):743-759. PubMed ID: 35125244
[TBL] [Abstract][Full Text] [Related]
14. Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells.
Hadinger KP; Marshalek JP; Sheeran PS; Dayton PA; Matsunaga TO
Ultrasound Med Biol; 2018 Dec; 44(12):2728-2738. PubMed ID: 30228045
[TBL] [Abstract][Full Text] [Related]
15. Concurrent anti-vascular therapy and chemotherapy in solid tumors using drug-loaded acoustic nanodroplet vaporization.
Ho YJ; Yeh CK
Acta Biomater; 2017 Feb; 49():472-485. PubMed ID: 27836803
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Assessment of the Potential for Renal Bio-Effects from the Vaporization of Perfluorocarbon Phase-Change Contrast Agents.
Nyankima AG; Rojas JD; Cianciolo R; Johnson KA; Dayton PA
Ultrasound Med Biol; 2018 Feb; 44(2):368-376. PubMed ID: 29254872
[TBL] [Abstract][Full Text] [Related]
17. Perfluorocarbon nanodroplet size, acoustic vaporization, and inertial cavitation affected by lipid shell composition in vitro.
Welch PJ; Li DS; Forest CR; Pozzo LD; Shi C
J Acoust Soc Am; 2022 Oct; 152(4):2493. PubMed ID: 36319242
[TBL] [Abstract][Full Text] [Related]
18. Polyvinyl Alcohol Cryogels for Acoustic Characterization of Phase-Change Contrast Agents.
Durham PG; Kim J; Eltz KM; Caskey CF; Dayton PA
Ultrasound Med Biol; 2022 May; 48(5):954-960. PubMed ID: 35246338
[TBL] [Abstract][Full Text] [Related]
19. Novel method for the formation of monodisperse superheated perfluorocarbon nanodroplets as activatable ultrasound contrast agents.
de Gracia Lux C; Vezeridis AM; Lux J; Armstrong AM; Sirsi SR; Hoyt K; Mattrey RF
RSC Adv; 2017; 7(77):48561-48568. PubMed ID: 29430294
[TBL] [Abstract][Full Text] [Related]
20. Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.
Marshalek JP; Sheeran PS; Ingram P; Dayton PA; Witte RS; Matsunaga TO
J Control Release; 2016 Dec; 243():69-77. PubMed ID: 27686582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
